Avego Management

PBS Biotech specializes in the manufacture of single-use bioreactor systems designed to provide homogeneous and scalable mixing conditions for various cell therapy products and cell culture applications. Their bioreactors feature the smallest per liter volume footprints and are fully scalable, accommodating all stages of the cell culture process, including research and development, clinical trials, and cGMP production. In addition to their innovative bioreactor systems, PBS Biotech offers a range of process development services, including cell therapy optimization, characterization, and risk analysis. By providing efficient and cost-effective disposable systems along with expert technical services, the company helps clients address complex cell culture challenges and enhance operational efficiency in their biomanufacturing processes.

AtomVie Global Radiopharma is a global Contract Development and Manufacturing Organization focused on advancing radiotherapeutics. The company supports startups and partners throughout the entire process, from early clinical development to commercial manufacturing. AtomVie offers a comprehensive suite of services, including scientific, technical, regulatory, quality, logistics, and business expertise, all backed by a specialized infrastructure. This enables clients to ensure reliable clinical supply and deliver high-quality drugs for the treatment and diagnosis of diseases, ultimately facilitating progress from initial phases to the commercial marketplace.

PBS Biotech specializes in the manufacture of single-use bioreactor systems designed to provide homogeneous and scalable mixing conditions for various cell therapy products and cell culture applications. Their bioreactors feature the smallest per liter volume footprints and are fully scalable, accommodating all stages of the cell culture process, including research and development, clinical trials, and cGMP production. In addition to their innovative bioreactor systems, PBS Biotech offers a range of process development services, including cell therapy optimization, characterization, and risk analysis. By providing efficient and cost-effective disposable systems along with expert technical services, the company helps clients address complex cell culture challenges and enhance operational efficiency in their biomanufacturing processes.

Escient Pharmaceuticals is a biotechnology company based in San Diego, California, that develops and manufactures drugs targeting G protein-coupled receptors (GPCRs) for the treatment of neuro-immuno-inflammatory and autoreactive diseases. Founded in 2017, the company specializes in harnessing the therapeutic potential of specific orphan GPCRs, particularly the Mas-Related G-Protein Receptors (Mrgprs), to address various neurosensory-inflammatory disorders. Escient's innovative approach aims to provide first-in-class therapies for conditions associated with mast cell-mediated disorders and cholestatic pruritus, thereby expanding treatment options for healthcare providers and patients facing these challenging diseases.

AtomVie Global Radiopharma is a global Contract Development and Manufacturing Organization focused on advancing radiotherapeutics. The company supports startups and partners throughout the entire process, from early clinical development to commercial manufacturing. AtomVie offers a comprehensive suite of services, including scientific, technical, regulatory, quality, logistics, and business expertise, all backed by a specialized infrastructure. This enables clients to ensure reliable clinical supply and deliver high-quality drugs for the treatment and diagnosis of diseases, ultimately facilitating progress from initial phases to the commercial marketplace.